menu

CKD in T2D: Exploring Strategies and Tools for Early Risk Assessment

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

CKD in T2D: Exploring Strategies and Tools for Early Risk Assessment

Program Information
Recommended

Program Information

ReachMD Healthcare Image
RestartResume

Learn more about tools that can be used to better risk assess and manage early-stage CKD in patients with T2D.

  • Sponsored by

  • Overview

    The rate of chronic kidney disease (CKD) in patients with type 2 diabetes (T2D) continues to rise. What can we do to slow this progression of CKD? Dr. Joseph Aloi from the Wake Forest School of Medicine explores this growing epidemic and discusses how a new tool may aid in early risk assessment of early stage 1-3b CKD.

Schedule7 Dec 2022